Brief Reports
Copyright ©The Author(s) 1999.
World J Gastroenterol. Apr 15, 1999; 5(2): 181-182
Published online Apr 15, 1999. doi: 10.3748/wjg.v5.i2.181
Table 2 Expression of T cell activated antigen and CD16 in pat ients with colorectal cancer (%, -x±s)
GroupsCasesCD16CD69CD3+/HLA-DR+
Control2511.11 ± 6.2510.98 ± 6.414.44 ± 3.22
Colorectal cancer before operation357.37 ± 2.61ac5.99 ± 2.07ac3.81 ± 1.72c
Colorectal cancer after operation3511.62 ± 4.2310.87 ± 2.817.62 ± 3.01b